Asilone discontinued in UK

28th March 2013

Asilone^® oral suspension (Thornton & Ross) an antacid containing simeticone 135mg, aluminium hydroxide 420mg and magnesium oxide 70mg/5mL has been discontinued in the UK. Alternative simeticone-containing antacid preparations are:

Maalox Plus^® (Sanofi Aventis)
Oral suspension (sugar-free) simeticone 25mg, dried aluminium hydroxide 220mg, magnesium hydroxide 195mg/5mL, 28days @ 5mL q.d.s = £3; low Na⁺.

Altacite plus^®(Peckforton)

Oral suspension (sugar-free) co-simalcite 125/500 (simeticone 125mg, hydrotalcite 500mg)/5mL 28days @ 10mL q.d.s = £7.50; low Na⁺.

See PCF Simeticone monograph.

click here to view

GMC publishes Good practice in prescribing and managing medicines and devices

28th March 2013

The General Medical Council has published it Good practice in prescribing and managing medicines and devices (2013), which came into effect on the 25 February 2013. It replaces Good practice in prescribing medicines (2008) and incorporates Remote prescribing via telephone, video-link or online (2012). It is available to view or download from the GMC website.

click here to view

Aqueous cream may cause skin irritation

27th March 2013

The UK Medicines and Healthcare products Regulatory Agency (MHRA) has warned that aqueous cream may cause skin irritation particularly in children with atopic eczema. The reactions may be due to the presence of sodium lauryl sulfate or other ingredients. If irritation occurs, treatment should be discontinued and an emollient that does not contain sodium lauryl sulfate should be tried.

click here to view

Die Januar/Februar Ausgabe des APM Newsletter ist fertig

26th March 2013

The January/February issue of the APM Newsletter for German-speaking users of www.palliativedrugs.com is available.
Der neue APM-Newsletter Jahrgang ist in der Ausgabe Januar/Februar erschienen. Über die aktuelle Ausgaben des Newsletters wird Sie das Bulletin Board informieren.

click here to view